Learn More
Thermo Scientific™ Pierce Protease Inhibitor Tablets
Description
Thermo Scientific™ Pierce Protease Inhibitor Tablets and Mini Tablets are broad-spectrum protease inhibitors that are highly effective at preventing proteolytic degradation for cell lysis and protein extraction experiments.
Thermo Scientific™ Pierce Protease Inhibitor Tablets and Mini Tablets are broad-spectrum protease inhibitors that are highly effective at preventing proteolytic degradation for cell lysis and protein extraction experiments.
Additional Information and Online Ordering
Pierce Protease Inhibitor Tablets protect proteins from proteolytic degradation through inhibition of the serine-proteases, cysteine-proteases, aspartic acid-proteases and aminopeptidases that are typically present in cellular lysate samples. The tablets contain AEBSF, aprotinin, bestatin, E-64, leupeptin and pepstatin A and are available in formulations with or without EDTA, a metalloproteinase inhibitor. The EDTA-free formulation has added compatibility with IMAC purification methods and 2D gel electrophoresis. Stable for storage at 4°C for up to 12 months, each large tablet is sufficient for 50mL of solution and each mini tablet is sufficient for 10mL of solution. Both sizes and formulations of tablet are suitable for reagent preparation prior to protein extraction from tissue and cultured cells.
Highlights:
- Economical −both large and mini tablets are most cost effective than other commercially available formulations for equivalent volumes
- Easy−to−use − the refrigerator−stable tablets are easily dissolved in buffers and lysis reagents
- Two formulation − available with or without EDTA
- Compatible − use with homebrew or commercially available cell lysis reagents and Thermo Scientific Protein Assays
Specifications
Specifications
| Description | Pierce Protease Inhibitor Tablets |
| Product Type | Protease Inhibitor |
| Content And Storage | 1 Vial, Store at 2°C to 8°C |
| Shipping Condition | Room Temperature |
| Form | Solid |
| Product Line | Pierce |
| Sufficient For | 50 mL Solution |
| Inhibitors | Protease Inhibitor |
| Quantity | 20 Tablets |
Frequently Asked Questions (FAQs)
Pierce Protease Inhibitor Tablets (Cat. No. A32963) dissolve quickly to form a clear solution. We recommend dissolving 1 tablet in 50 mL of buffer or lysate. The protease inhibitor formulation is compatible with most detergent-based cell lysis reagents, including Pierce Cell Lysis solutions. Pierce Protease Inhibitor Tablets do not contain phosphatase inhibitors. If necessary, phosphatase inhibitors, such as Pierce Phosphatase Inhibitor Mini Tablets (Cat. No. A32957) can be added along with the protease inhibitor tablets.
We do not recommend splitting the capsule into smaller portions. Researchers using less than 500 mL should choose a different format (liquid or tablet) of protease inhibitors.
We offer standalone protease inhibitors (AEBSF, Aprotinin, PMSF, EDTA, etc.), as well as cocktails or combinations of protease inhibitors in liquid, tablet, and larger capsule formats. These cocktails of protease inhibitors can also be purchased in combination with a cocktail of phosphatase inhibitors, in both liquid and tablet form, for even greater convenience.
Yes, the following components of the Pierce protease, phosphatase and (protease and phosphatase) inhibitor tablets and mini tablets are offered separately:
- AEBSF (Cat. No. 78431)
- Aprotinin (Cat. No. 78432)
- Bestatin (Cat. No. 8433)
- E-64 (Cat. No. 78434)
- Leupeptin (Cat. No. 78435)
- Pepstatin A (Cat. No. 78436)
- EDTA (Cat. No. 17892).
The final concentration of each component in the protease and phosphatase inhibitor tablets and mini tablets is proprietary. We release only the identities of the inhibitors.
For Research Use Only. Not for use in diagnostic procedures.